The FDA said four people who received a placebo and two who received the Pfizer vaccine died.
In the United States, six people died during a trial of a vaccine developed by the American company Pfizer and the German BioNTech, which is 0.01% of all study participants. This is reported in the report FDA – American Food and Drug Administration (.pdf).
There were six deaths during the reporting period, according to the department. Two deaths occurred in the group that received the vaccine, four more in the group that received the placebo, the document says.
More than 43.4 thousand people took part in testing the vaccine. The report summarizes data from studies that were conducted from April 29 to November 14, 2020.
The first victim of the vaccinated group had atherosclerosis. The volunteer died three days after the first dose of the drug. The second deceased participant from this group had a heart failure 60 days after the second dose, and he died three days later, the report noted.
According to the study, of those who were injected with a placebo, two people died of stroke and heart attack. The causes of death of two more people from this group are being investigated.
Five of the six who died were over 55, the report said.
Pfizer Nov 18 announced 95% efficiency BNT162b2 vaccines against COVID-19.
Head of the World Health Organization Tedros Adhanom Ghebreyesus called the Pfizer vaccine “very promising”.
FDA 8 december confirmed the safety and efficacy of the vaccine BNT162b2 and concluded that “specific security problems” that would prevent the issuance of a permit for use of the vaccine in an emergency, no. On the same day in the UK the world’s first large-scale vaccination began the population from coronavirus infection, the British are injected with the vaccine BNT162b2.
Pfizer and BioNTech calculate produce up to 50 million doses of vaccine in 2020 and up to 1.3 billion by the end of 2021.
– .